Scorpius BioManufacturing is an integrated CDMO focused on rapidly advancing mammalian and microbial biologic programmes to the clinic and beyond. With end-to-end capabilities from discovery to limited-scale commercial production, the company provides a broad array of R&D, analytical testing, and manufacturing services to pharmaceutical and biotech companies. With an experienced team and new, purpose-built, U.S. facilities, Scorpius is dedicated to easily accessible, transparent collaboration and flexible biologics biomanufacturing.

Services include:
– Biologics
– Cell and Gene Therapy
– Assay Development
– Bioprocessing
– Contract Manufacturing (CMO)
– Fermentation
– Manufacturing
– Microbial-based Therapeutic Proteins
– Proteins
– Vaccines
– Process Development
– Quality QA/QC
– Technology Transfer
– Protein and Peptide
– Analytical Services

Scorpius BioManufacturing is committed to delivering high-quality biomanufacturing solutions tailored to meet the diverse needs of its clients. For more information, please visit scorpiusbiologics.com.